Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.

Data from DELIVER and ACHIEVE Clinicals Trial to be Presented -- Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on ...

Jim Ryan; Vice President - Investor Relations; Curtiss-Wright Corp. Lynn Bamford; Chairman of the Board, Chief Executive Officer; Curtiss-Wright Corp. K. Christopher ...

Jumbo phages utilize a complex protein import system, with Imp1 as a key gatekeeper, to transport proteins into their ...

Wide-moat GE HealthCare, or GEHC, is a top three global leader in the medical imaging market. It has a firmly established footprint in hospitals and health networks around the world, and it is ...

Perfect Moment Ltd. (NYSE American: PMNT), the high-performance, luxury skiwear and lifestyle brand that fuses technical excellence with fashion-led d ...

Q4 2024 Earnings Call Transcript February 13, 2025 Gogoro Inc. misses on earnings expectations. Reported EPS is $-0.25 EPS, ...

The physical interaction with the environment through grasping is critical for many robotic applications, particularly in dynamic and unstructured settings ...

US - Court Reverses Itself In AI Training Data Case. Legal News and Analysis - USA - Telecommunications, Media & Technology - ...

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...

When organizations prioritize a clear purpose over profit, they have a positive influence on consumers and stakeholders of ...

No-code platforms can offer the ability to surface business insights, but their true value lies in enabling action.